These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8983126)

  • 1. Endothelial markers in diabetes mellitus.
    Galajda P; Martinka E; Mokán M; Kubisz P
    Thromb Res; 1997 Jan; 85(1):63-5. PubMed ID: 8983126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemostasis in patients with diabetes mellitus. I. Markers of endothelial dysfunction].
    Galajda P; Martinka E; Kubisz P; Ivanková J; Galajdová E; Polko J; Mokán M
    Vnitr Lek; 1996 Oct; 42(10):676-9. PubMed ID: 8975457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
    Fujiwara Y; Tagami S; Kawakami Y
    J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus].
    Galajda P; Martinka E; Baláz D; Stasko J; Kerný J; Planková E; Mokán M; Kubisz P
    Vnitr Lek; 1997 Nov; 43(11):744-7. PubMed ID: 9650506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome.
    Bajaj MS; Tricomi SM
    Intensive Care Med; 1999 Nov; 25(11):1259-66. PubMed ID: 10654210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
    Leurs PB; Stolk RP; Hamulyak K; Van Oerle R; Grobbee DE; Wolffenbuttel BH
    Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease.
    Hirano T; Ookubo K; Kashiwazaki K; Tajima H; Yoshino G; Adachi M
    Clin Chim Acta; 2000 Sep; 299(1-2):65-75. PubMed ID: 10900293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor.
    Aso Y; Fujiwara Y; Tayama K; Takanashi K; Inukai T; Takemura Y
    Exp Clin Endocrinol Diabetes; 2001; 109(4):210-6. PubMed ID: 11453033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers of endothelial activation in primary hyperparathyroidism.
    Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
    Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
    Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
    Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
    Nadar SK; Al Yemeni E; Blann AD; Lip GY
    Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?
    Niemir ZI; Kubiak A; Olejniczak P; Nowak A; Czekalski S
    Rocz Akad Med Bialymst; 2004; 49():213-8. PubMed ID: 15631346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral endothelial injury in severe head injury: the significance of measurements of serum thrombomodulin and the von Willebrand factor.
    Yokota H; Naoe Y; Nakabayashi M; Unemoto K; Kushimoto S; Kurokawa A; Node Y; Yamamoto Y
    J Neurotrauma; 2002 Sep; 19(9):1007-15. PubMed ID: 12482114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
    Chong AY; Blann AD; Patel J; Freestone B; Hughes E; Lip GY
    Circulation; 2004 Sep; 110(13):1794-8. PubMed ID: 15364797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma vascular endothelial cell growth factor and thrombomodulin in juvenile diabetic patients.
    McLaren M; Elhadd TA; Greene SA; Belch JJ
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):21-4. PubMed ID: 10725978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
    Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.
    Morange PE; Simon C; Alessi MC; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Juhan-Vague I;
    Circulation; 2004 Mar; 109(11):1343-8. PubMed ID: 15023872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF.
    Bellucci S; Ignatova E; Jaillet N; Boffa MC
    Thromb Haemost; 1993 Nov; 70(5):736-42. PubMed ID: 8128427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.